Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is reporting fourth quarter financial results on Wednesday 13th June 2018, after the bell.
According to analysts surveyed by Thomson Reuters, SNOA is expected to report 4Q18 loss of $ 0.59 per share from revenue of $ 4.49 million.
The same period from last year, SNOA reportedly had loss of $ 0.57 per share on $ 4.03 million in revenue.
For the full year, analysts anticipate top line of $ 17.49 million, while looking forward to loss of $ 2.79 per share bottom line.
About Sonoma Pharmaceuticals, Inc.
|% Change from 52 Week Low|
|% Change from 52 Week High|